Queen Mary researchers ID osteoarthritis treatment; MGH team studies tau; Checkpoint researchers explore resistance;

> A drug that disrupts the length of the cell's antennae, called primary cilia, may be effective as a treatment for osteoarthritis, according to bioengineers from Queen Mary University of London. Release

> A team at Massachusetts General Hospital have been exploring how tau tangles associated with Alzheimer's spread in the brain. Release

> Investigators at the University of Michigan say they've shed new light on explaining why many patients don't respond to a checkpoint inhibitor. Release

> Researchers ID'd 1,450 genes which been linked to the ageing process. Release

Suggested Articles

A newfound link between BMAL1, a protein involved in circadian rhythms, and triple-negative breast cancer could point to new treatment strategies.

Combining a DYRK1A inhibitor with popular GLP-1 receptor agonists regenerates insulin-producing beta cells, Mount Sinai scientists found.

Arming a peptide taken from the virus that causes foot-and-mouth disease in cows with the payload tesirine shows promise against pancreatic cancer.